M. Ian Somaiya

Chief Financial Officer at TCR2 Therapeutics, Inc.

M. Ian Somaiya

M. Ian Somaiya

Chief Financial Officer at TCR2 Therapeutics, Inc.

Overview
Career Highlights

TCR2 Therapeutics, Inc.

RelSci Relationships

4000

Contact Data
Trying to get in touch with M. Ian Somaiya? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals M. Ian Somaiya likely has professional access to. A relationship does not necessarily indicate a personal connection.

CSO & Co-Founder at Cullinan Oncology LLC

Relationship likelihood: Strong

Analyst at BMO Capital Markets Corp. (Canada)

Relationship likelihood: Strong

Director, President & Chief Executive Officer at TCR2 Therapeutics, Inc.

Relationship likelihood: Strong

Analyst at BMO Capital Markets Corp. (Canada)

Relationship likelihood: Strong

Global Head of Human Resources at Nomura Holdings, Inc.

Relationship likelihood: Strong

Managing Director & Head, Equity Syndicate-America at Nomura Holdings, Inc.

Relationship likelihood: Strong

Future Representative Executive Officer, President & Group Chief Executive Officer at Nomura Holdings, Inc. (Effective 04/2020)

Relationship likelihood: Strong

Analyst at BMO Capital Markets Corp. (Canada)

Relationship likelihood: Strong

Chief Legal Officer & Executive Officer at Nomura Holdings, Inc.

Relationship likelihood: Strong

Executive Officer & Deputy Head-Americas Region at Nomura Holdings, Inc.

Relationship likelihood: Strong

Paths to M. Ian Somaiya
Potential Connections via
Relationship Science
You
M. Ian Somaiya
Chief Financial Officer at TCR2 Therapeutics, Inc.
Education
Class of 1995
Career History
Chief Financial Officer
2018 - Current

TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering T-cells for cancer therapy. The company offers cancer therapy, T-cell biology, Immunology and Molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded in May 2015 and is headquartered in Cambridge, MA.

Managing Director & Senior Analyst, US Biotechnology Sector
2013 - Current

Nomura Holdings, Inc. operates as a holding company which provides the investment and financial services. It operates through the following segments: Retail, Asset Management, Wholesale and Merchant Banking. The Retail segment includes investment consultation services, distribution of trust certificates, and management of insurance agencies. The Asset Management segment offers portfolio and trust management, and provides investment advisory services for pension funds. The Wholesale segment consists of global markets and investment banking services such as trading of bonds, stocks, foreign exchange, and derivatives, and the underwriting of debt, equity, and other financial instruments. The Merchant Banking offers equity to clients as a solution for business reorganizations and revitalizations, business succession and management buyouts. The company was founded by Tokushichi Nomura on December 25, 1925 and is headquartered in Tokyo, Japan.

Analyst
Current

Founded in 1817, BMO Capital Markets is a full-service North American financial services firm that offers corporate, institutional and government clients access to a variety of financial products and services including equity and debt underwriting, corporate lending and project financing, merger and acquisitions advisory services, merchant banking, securitization, treasury management, market risk management, debt and equity research and institutional sales and trading. The firm is the investment and corporate banking arm of BMO Financial Group and their ultimate parent is the Bank of Montreal (NYSE, TSX: BMO).

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by M. Ian Somaiya. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of M. Ian Somaiya's profile does not indicate a business or promotional relationship of any kind between RelSci and M. Ian Somaiya.